[Biopterin and child neurologic disease]

Area of Science:

• Biochemistry
• Genetics
• Neurology

Context:

• Tetrahydrobiopterin (BH4) is a vital cofactor for amino acid metabolism and neurotransmitter synthesis.
• BH4 deficiencies can lead to hyperphenylalaninemia and neurotransmitter deficits, causing neurological impairment.
• Newborn screening typically detects BH4 deficiencies linked to phenylketonuria, but other forms may be missed.

Purpose:

• To highlight the biochemical pathways involving BH4 and its role in human health.
• To differentiate between BH4 deficiencies detected by newborn screening and those that are not.
• To emphasize the clinical presentation and diagnostic approaches for various BH4 deficiency types.

Summary:

• BH4 deficiencies disrupt phenylalanine metabolism and neurotransmitter biosynthesis.
• Autosomal dominant GTPCH deficiency (Segawa's disease) and autosomal recessive SR deficiency cause BH4 and neurotransmitter deficiencies without hyperphenylalaninemia.
• Diagnostic methods include BH4 loading tests, pteridine analysis, DHPR activity measurement, and cerebrospinal fluid neopterin/biopterin levels.

Impact:

• Ensures timely diagnosis and intervention for patients with BH4 deficiencies, preventing severe neurological damage.
• Raises awareness among clinicians to consider BH4 and biopterin metabolic disorders in pediatric neurological conditions.
• Improves understanding of the genetic and biochemical basis of these rare disorders, aiding further research.